• Latest
  • Trending
Yemaachi, Ghanaian Cancer Diagnostic Startup secures $3M seed to Diversify Genomic Datasets

Yemaachi, Ghanaian Cancer Diagnostic Startup secures $3M seed to Diversify Genomic Datasets

March 30, 2022
Healthcare Innovation Summit Africa 2025 returns to Johannesburg with focus on digital transformation

Healthcare Innovation Summit Africa 2025 returns to Johannesburg with focus on digital transformation

September 26, 2025
Pearl Nkrumah becomes the first female MD of Access Bank Ghana

Pearl Nkrumah becomes the first female MD of Access Bank Ghana

September 26, 2025
Verto opens new strategic hub in Nairobi to simplify global trade for emerging markets

Verto opens new strategic hub in Nairobi to simplify global trade for emerging markets

September 26, 2025
Revolut seeks South African banking license

Revolut seeks South African banking license

September 26, 2025
Nokia, Nscale partner to facilitate the deployment of AI infrastructure

Nokia, Nscale partner to facilitate the deployment of AI infrastructure

September 26, 2025
PayPal commits $100 million to boost digital economy in Middle East and Africa

PayPal commits $100 million to boost digital economy in Middle East and Africa

September 26, 2025
Mastercard, Smile ID partner to launch fraud-prevention digital identity solutions

Mastercard, Smile ID partner to launch fraud-prevention digital identity solutions

September 26, 2025
Google combines Android and ChromeOS for a new PC system

Google combines Android and ChromeOS for a new PC system

September 26, 2025
Orange Egypt partners with mnGm to introduce gold trading via mobile wallets

Orange Egypt partners with mnGm to introduce gold trading via mobile wallets

September 26, 2025
BII injects $20 million into Acumen initiative targeting Africa’s off-grid communities

BII injects $20 million into Acumen initiative targeting Africa’s off-grid communities

September 26, 2025
Your one-stop tech hub! Get the latest updates on AI, cybersecurity, fintech, and emerging technologies.
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Tech TV
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Tech TV
    • General News
    • How To
    • Reviews
  • Cryptocurrency
  • Fintech
  • Startups
  • Ai
No Result
View All Result
Techpression
No Result
View All Result
Home Business

Yemaachi, Ghanaian Cancer Diagnostic Startup secures $3M seed to Diversify Genomic Datasets

Staff Writer by Staff Writer
March 30, 2022
146 6
0
Yemaachi, Ghanaian Cancer Diagnostic Startup secures $3M seed to Diversify Genomic Datasets
470
SHARES
Share on FacebookShare on TwitterWhatsAppTelegram

Ghanaian cancer research and diagnostic Yemaachi Biotech has announced raising $3 million in a seed round led by V8 Capital to further its aim of global precision oncology diversification.

The round saw the participation of LifeLine Family Heritage Fund, Y Combinator, Tencent, LoftyInc Capital, VestedWorld, V Square Capital, and Ethan Perlstein.

Yemaachi Biotech was founded in 2020 by Yaw Bediako, David Hutchful, Joyce Ngoi, and Yaw Attua-Afari. With a dedication to accelerating precision oncology in Africa and beyond, Yemaachi has developed a first-of-its-kind pan-African genomic and clinical knowledge base and research platform, which, when combined with deep clinical partnerships across Africa, provides the foundation for innovative products and partnerships to advance new molecular diagnostics and therapeutic targets.

CEO of Yemaachi, Yaw Bediako

RelatedPosts

Endeavor Catalyst to raise $300 million to boost MENA startups amid global funding crunch

African startups secure $343 million in funding across 39 deals in April 2025

Ghanaian AI startup Aya Data secures $900K seed funding

The co-founder and CEO of Yemaachi, Yaw Bediako, said — “We’ve only begun to scratch the surface of genomic data and understanding. We know genetic outcomes are context-dependent, including within the genome. Creating a dataset with the greatest genomic diversity can enable rapid discoveries that have long-term implications for cancer research, drug development, and patient care, not just in Africa but also globally.”

 

Read Also : Egyptian SaaS Platform FlapKap secures $1.2M funding

 

“Combined with Yemaachi’s expertise in immunogenomics, bioinformatics, and deep learning, the company’s expansive datasets can be a force multiplier for rapidly accelerating advancements in oncology,” he added.

Last year, Yemaachi was one of 15 African companies to be selected for the S21 batch of the Y Combinator accelerator and has now followed that with a US$3 million seed round. Yemaachi was also recently named a beneficiary of a $1 million grant from the Bill and Melinda Gates Foundation’s Calestous Juma Science Leadership Fellowship, awarded to Bediako. The fellowship is done to support scientists attempting to find breakthroughs in critical global health issues.

 

Read Also : MTN and Huawei signs 5G MOU with two mining companies in South Africa

 

Commenting on the seed round investment, Tobi Oke, managing partner at V8 Capital Partners, said — “The breadth of expertise of Yemaachi’s highly talented founding team, the clinical partnerships they have already formed, and their focus on leveraging the vast untapped resource of African genetic diversity to discover the next generation of cancer diagnostics and therapeutics makes them a stimulating and valuable investment for us.”

About Yemaachi Biotech

Yemaachi is a cancer research and diagnostic company using cutting-edge immunogenomics, bioinformatics, and artificial intelligence to accelerate the development of cancer detection and cure strategies that have high efficacy regardless of ethnicity.

The company is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa and using the data to optimize existing diagnostic tests or discover new ones. With research activities based in Africa, Yemaachi is able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledge base on cancer.

Tags: Cancer researchFundingYemaachi
Staff Writer

Staff Writer

No Result
View All Result

Quick Links

  • Tech News
  • Cryptocurrency
  • Fintech
  • Startups
  • Business

Follow Us:

  • facebook
  • instagram
  • Twitter(X)
  • Linkedin
  • YouTube
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 Techpression.com -Techpression Media Limited

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

No Result
View All Result
  • Home
  • Tech News
    • Africa Tech
    • Global Tech
    • Tech with Pelumy
    • Tech Careers
    • Reviews
    • How To
    • General News
  • Cryptocurrency
  • Business
  • Fintech
  • Startups
  • Featured
  • Ai
  • Tech TV

© 2025 Techpression.com -Techpression Media Limited

techpression.com
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.